Omar Fakhri

Dr. Omar Fakhri (Arabic: الدكتور عمر فخري; born 18 October 1934) is an Iraqi medical scientist who is best known for his research in several areas: the role of vitamin K in treating hemorrhagic diathesis in children, the cooperation between antibodies and lymphocytes and their role in immune response, the use of peritoneal macrophages in the treatment of resistant infections in leukemia patients, the effect of electroconvulsive therapy on diabetes and the use of low voltage electrotherapy in the treatment of resistant skin burns, psoriasis, exophthalmos, aplastic anaemia and other diseases.

In 1961, he was granted a fellowship by the International Atomic Energy Agency for a year of further training at University College Hospital in London on the medical application of isotopes.

[1][2][3] During that period he also worked at the Institute of Ophthalmology, where he also successfully treated a number of exophthalmos cases using the electrotherapy methods he had developed in Baghdad.

Fakhri's work has been published in a number of international medical journals and presented at scientific conferences in the United States, Sweden, Denmark, Egypt, Turkey and Hungary.

In 1959, Fakhri, Tajeldin, and Nouri at the Children's Welfare Hospital in Baghdad discovered that these patients had low prothrombin, which is essential for blood clotting.

[5] During his PhD research, Fakhri carried out a series of experiments to determine an effective method to treat cancer with immunotherapy.

[11] Dr. Fakhri, Fadhli and El Rawi[12] then conducted a larger study on diabetic patients with depression and reported the benefits associated with ECT in The Lancet in 1980.

[18] Although the effect of low voltage electrotherapy on the body is still not fully understood, it has been well established that it improves circulation and stimulates tissue growth.

In addition, it appears to have beneficial effects with regard to various autoimmune diseases and assist in regulating an imbalanced immune system.